SCHEMBL19538024

SCHEMBL19538024

O=C(Cn1nnc(-c2ccccc2)n1)NC(=O)Nc1ccccc1F

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 5/20 0.55
ALDH1A1 P00352 4/20 0.55
TP53 P04637 3/20 0.53
TSHR P16473 2/20 0.53
HPGD P15428 3/20 0.52
KDM4E B2RXH2 5/20 0.50
KMT2A Q03164 4/20 0.50
L3MBTL1 Q9Y468 2/20 0.50
CTDSP1 Q9GZU7 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
LMNA P02545 2/20 0.49
MEN1 O00255 2/20 0.49
ATM Q13315 1/20 0.49
ADRB2 P07550 1/20 0.49
MAPT P10636 1/20 0.49
HTT P42858 1/20 0.49
KCNJ6 P48051 1/20 0.49
KCNJ5 P48544 1/20 0.49
KCNJ3 P48549 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19538023 0.78 ALDH1A1 (0.59) POLBALDH1A1TP53TSHRHPGD
SCHEMBL20915691 0.78 KDM4E (0.56) POLBALDH1A1TP53TSHRHPGD
SCHEMBL1061767 0.76 KMT2A (0.72) POLBALDH1A1TP53TSHRHPGD
SCHEMBL20931185 0.75 KDM4E (0.59) POLBALDH1A1TP53TSHRKDM4E
SCHEMBL8215669 0.74 HPGD (0.70) POLBALDH1A1TP53TSHRHPGD
SCHEMBL3282703 0.73 MEN1 (0.72) POLBALDH1A1TP53TSHRHPGD
SCHEMBL19784943 0.73 DDX3X (0.77) POLBKDM4EKMT2ACTDSP1SMN1; SMN2
SCHEMBL4024534 0.72 HPGD (0.76) POLBALDH1A1HPGDKMT2AL3MBTL1
SCHEMBL19520629 0.72 GAA (0.57) POLBALDH1A1TP53TSHRHPGD
SCHEMBL19538198 0.71 TP53 (0.66) POLBALDH1A1TP53TSHRHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109153655-B Novel N-acylurea derivatives and compositions comprising the same for preventing or treating cardiovascular diseases 高丽大学校产学协力团 2022-09-30 CN claimed
CN-109153655-B Novel N-acylurea derivatives and compositions comprising the same for preventing or treating cardiovascular diseases 高丽大学校产学协力团 2022-09-30 CN disclosed
US-20220194928-A1 NOVEL N-ACYLUREA DERIVATIVE AND COMPOSITION COMPRISING SAME FOR PREVENTION OR TREATMENT OF CARDIOVASCULAR DISEASE UNIV KOREA RES & BUS FOUND (KR) 2022-06-23 US disclosed
US-11306073-B2 N-acylurea derivative and composition comprising same for prevention or treatment of cardiovascular disease KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION (KR) 2022-04-19 US disclosed
US-20190119261-A1 NOVEL N-ACYLUREA DERIVATIVE AND COMPOSITION COMPRISING SAME FOR PREVENTION OR TREATMENT OF CARDIOVASCULAR DISEASE KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION (KR) 2019-04-25 US disclosed
WO-2017188551-A1 NOVEL N-ACYLUREA DERIVATIVE AND COMPOSITION COMPRISING SAME FOR PREVENTION OR TREATMENT OF CARDIOVASCULAR DISEASE 고려대학교산학협력단 2017-11-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190119261-A1 NOVEL N-ACYLUREA DERIVATIVE AND COMPOSITION COMPRISING SAME FOR PREVENTION OR TREATMENT OF CARDIOVASCULAR DISEASE TLN1, TNNI3, PTK2 POLB 4514/4885ALDH1A1 2072/4885TP53 4267/4885
US-20220194928-A1 NOVEL N-ACYLUREA DERIVATIVE AND COMPOSITION COMPRISING SAME FOR PREVENTION OR TREATMENT OF CARDIOVASCULAR DISEASE TLN1, TNNI3, PTK2 POLB 4514/4885ALDH1A1 2072/4885TP53 4267/4885
US-11306073-B2 N-acylurea derivative and composition comprising same for prevention or treatment of cardiovascular disease TLN1, PTK2, TNNI3 POLB 4459/4885ALDH1A1 1910/4885TP53 4197/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.